The first two were on diabetes and knee pain
The ones waiting for the trend to become undeniable are ceding that window, and Circanas analysis adds a further layer of urgency: the categories with the steepest GLP-1 spending declines are often the same categories with the most bloated SKU counts, the result of years of incremental product extensions that made sense when volume was growing but become expensive to maintain as demand contracts
Retatrutide Purity and Stability Because of retatrutide's triple receptor activation and participation in tightly regulated signaling pathways, even small amounts of peptide impurities or degradation products can introduce unintended receptor interactions or alter downstream signaling responses in experimental models
While the costs of the two medications are similar, there is research that highlights semaglutide GLP-1 as the more cost-effective option when it comes to weight loss treatment
GLP-1 Analogues Market Key Takeaways In terms of revenue, the global GLP-1 analogues market was valued at USD 66.48 billion in 2025
Tirzepatide (Mounjaro) Mounjaro is approved to treat type 2 diabetes
